Zhaotong, Yunnan, China In 2015 was created Yahui Precision Medicine Fund, which is appeared as VC. The venture was found in Asia in China. The main department of described VC is located in the Zhaotong.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Diagnostics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight GeneCast Biotechnology, Qitan Technology, Yingsheng Biology.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Yahui Precision Medicine Fund, startups are often financed by Empower Investment, Tsinghua Technology Transfer Fund, Tsinghua Holdings. The meaningful sponsors for the fund in investment in the same round are Matrix Partners China, Hanwang Technology, Cowin Venture. In the next rounds fund is usually obtained by Matrix Partners China, Xiamen C&D Corporation, TMT Investments.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Bennesse Holdings | Japan, Okayama, Okayama Prefecture |
| Caxton Advantage Life Sciences Fund | New York, New York, United States |
| EBSCO | Ipswich, Suffolk, United Kingdom |
| FamilySearch | Salt Lake City, United States, Utah |
| Investo Capital | Aalborg, Denmark, North Denmark Region |
| KP Engineering | Texas, Tyler, United States |
| Nedbank Corporate and Investment Banking | Gauteng, Sandown, South Africa |
| RCM Business | Bhilwara, India, Rajasthan |
| Riceland HealthCare | Texas, United States, Winnie |
| Sarissa Capital Management | - |
| Singh Capital Partners | Maryland, Potomac, United States |
| TechnoStart | Germany, Ludwigsburg, Mecklenburg-Vorpommern |
| TF1 Group | Boulogne, France, Nord-Pas-de-Calais |
| Tianjin Jiying Keji Fazhan Hehuo Qiye | China, Guangdong, Tianjin |
| Travis Perkins | England, Northamptonshire, United Kingdom |
| UHT Investments | Dubai, United Arab Emirates |
| Venustech | Beijing, Beijing, China |
| Whole Foods Market | Austin, Texas, United States |
| Zhongran North Coal | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Neukio Biotherapeutics | $50M | 02 Sep 2022 | Shanghai, Shanghai, China | ||
ComGen Biopharmaceutical | 18 Nov 2021 | Shanghai, Shanghai, China | |||
| $15M | 13 May 2020 | Qingyang District, Sichuan | |||
| 08 Apr 2019 | China, Beijing | ||||
Datu Medical | $2M | 29 Mar 2019 | Shanghai, Shanghai, China | ||
Yingsheng Biology | 21 Jul 2018 | Lixia District, Shandong | |||
Adlai Nortye | $53M | 26 Jun 2018 | Shangcheng District, Zhejiang, China | ||
| $3M | 15 Mar 2018 | China, Beijing | |||
23Mofang | $15M | 05 Mar 2018 | Qingyang District, Sichuan, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Neukio Biotherapeutics | $50M | 02 Sep 2022 | Shanghai, Shanghai, China | ||
ComGen Biopharmaceutical | 18 Nov 2021 | Shanghai, Shanghai, China | |||
| $15M | 13 May 2020 | Qingyang District, Sichuan | |||
| 08 Apr 2019 | China, Beijing | ||||
Datu Medical | $2M | 29 Mar 2019 | Shanghai, Shanghai, China | ||
Yingsheng Biology | 21 Jul 2018 | Lixia District, Shandong | |||
Adlai Nortye | $53M | 26 Jun 2018 | Shangcheng District, Zhejiang, China | ||
| $3M | 15 Mar 2018 | China, Beijing | |||
23Mofang | $15M | 05 Mar 2018 | Qingyang District, Sichuan, China |
